ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print May 30, 2007
Eur Respir J 2007, doi:10.1183/09031936.00004907
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
30/4/653    most recent
09031936.00004907v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bos, S.T.
Right arrow Articles by Zaagsma, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bos, S.T.
Right arrow Articles by Zaagsma, J.


ORIGINAL ARTICLE

Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison

S.T. Bos 1, R. Gosens 2*, A.B. Zuidhof 1, D. Schaafsma 1, A.J. Halayko 3, H. Meurs 1, J. Zaagsma 1

1 Dept of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands
2 Dept of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands; and Dept of Physiology, University of Manitoba, Winnipeg, Canada
3 Dept of Physiology, University of Manitoba, Winnipeg, Canada

* To whom correspondence should be addressed. E-mail: r.gosens{at}rug.nl.


   Abstract

Chronic inflammation in asthma and COPD drives pathological structural remodelling of the airways. Using tiotropium bromide, acetylcholine was recently identified by us to play a major regulatory role in airway smooth muscle remodelling in a guinea pig model of ongoing allergic asthma. We now aimed to investigate other aspects of airway remodelling and to compare the effectiveness of tiotropium to the glucocorticosteroid budesonide.

Ovalbumin-sensitized guinea pigs were challenged for twelve weeks with aerosolized ovalbumin, which induced airway smooth muscle thickening, hypercontractility of tracheal smooth muscle, increased pulmonary contractile protein (sm-myosin) abundance, mucus gland hypertrophy, an increase in MUC5AC positive goblet cells and eosinophilia. We reported previously that treatment with tiotropium inhibits airway smooth muscle thickening and contractile protein expression, and prevents tracheal hypercontractility. Our current studies demonstrate that tiotropium also fully prevented allergen-induced mucus gland hypertrophy, and partially reduced the increase in MUC5AC positive goblet cells and infiltrated eosinophils. Treatment with budesonide also prevented airway smooth muscle thickening, contractile protein expression, tracheal hypercontractility and mucus gland hypertrophy, and partially reduced MUC5AC positive goblet cells and eosinophilia.

This study demonstrates that tiotropium and budesonide are similarly effective in inhibiting several aspects of airway remodelling, providing further evidence that the beneficial effects of tiotropium bromide might exceed bronchodilation.

Keywords:  Airway remodelling, airway smooth muscle, anticholinergics, asthma, glucocorticosteroids, mucus hypersecretion




This article has been cited by other articles:


Home page
Eur Respir JHome page
S. Haag, S. Matthiesen, U. R. Juergens, and K. Racke
Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
Eur. Respir. J., September 1, 2008; 32(3): 555 - 562.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Meurs, R. Gosens, and J. Zaagsma
Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Eur. Respir. J., August 1, 2008; 32(2): 487 - 502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the European Respiratory Society.